COVID‐19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15202
Abstract: There have been reports of skin rash developing in patients with COVID‐19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular skin rash while taking favipiravir. read more here.
Keywords: covid favipiravir; adverse reactions; favipiravir induce; induce cutaneous ... See more keywords